Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
Chen‐Hua Liu(National Taiwan University Hospital), Jia‐Horng Kao(National Taiwan University Hospital), Chi‐Yi Chen(National Taiwan University), Tsai‐Yuan Hsieh(Tri-Service General Hospital), Chih‐Lin Lin(Chung Shan Medical University Hospital), Pei‐Jer Chen(National Taiwan University), Ding‐Shinn Chen(Nanyang Institute of Technology), Sheng‐Shun Yang(Taichung Veterans General Hospital), Cheng‐Yuan Peng(China Medical University), Chun‐Jen Liu(National Taiwan University), Pin‐Nan Cheng(National Cheng Kung University Hospital), Yen‐Cheng Chiu(National Cheng Kung University Hospital), Yu‐Lueng Shih(Tri-Service General Hospital), Hung‐Chih Yang(Johns Hopkins University), Yu‐Jen Fang(National Taiwan University), Tung‐Hung Su(National Taiwan University)
Cited by 9
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
|Immunity|2012|707
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653